- Home
- LXEH vs ANVS Comparison
LXEH vs ANVS Comparison
Compare LXEH & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LXEH | ANVS |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1M | 111.3M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LXEH | ANVS |
|---|---|---|
| Price | $0.31 | $4.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 218.5K | ★ 4.0M |
| Earning Date | 12-30-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,585,942.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.27 | $1.11 |
| 52 Week High | $50.08 | $6.37 |
Technical Indicators
Market Signals| Indicator | LXEH | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 29.50 | 56.79 |
| Support Level | $0.27 | $4.12 |
| Resistance Level | $0.30 | $4.64 |
| Average True Range (ATR) | 0.02 | 0.52 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 19.18 | 25.56 |
Price Performance
Historical ComparisonAbout LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.